BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28864833)

  • 21. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?
    Hishida T; Yoshida J; Maeda R; Ishii G; Aokage K; Nishimura M; Nagai K
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):772-7. PubMed ID: 22864791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer.
    Gabor S; Renner H; Popper H; Anegg U; Sankin O; Matzi V; Lindenmann J; Smolle Jüttner FM
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):439-42. PubMed ID: 15019675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
    Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
    Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical outcomes in resected non-small cell lung cancer < or = 1 cm in diameter.
    Wang BY; Hung JJ; Jeng WJ; Hsu WH; Hsieh CC; Huang MH; Huang BS; Liu JS; Wu YC
    J Chin Med Assoc; 2010 Jun; 73(6):308-13. PubMed ID: 20603088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Observation of CT-guided Radiofrequency Ablation of Lung Neoplasm in 476 Consecutive Patients by a Thoracic Surgical Service: A Single-institutional Experience.
    Huang BY; Zhou JJ; Yu ZQ; Song XY; Lin Y; Li XM; Li L
    Acad Radiol; 2017 Dec; 24(12):1517-1525. PubMed ID: 28888381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
    Hung JJ; Hsu WH; Hsieh CC; Huang BS; Huang MH; Liu JS; Wu YC
    Thorax; 2009 Mar; 64(3):192-6. PubMed ID: 19252018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer.
    Inoue M; Minami M; Sawabata N; Utsumi T; Kadota Y; Shigemura N; Okumura M
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1445-9. PubMed ID: 20137967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
    Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients.
    Goodgame B; Viswanathan A; Zoole J; Gao F; Miller CR; Subramanian J; Meyers BF; Patterson AG; Govindan R
    J Thorac Oncol; 2009 Nov; 4(11):1370-4. PubMed ID: 19692932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatectomy for oligo-recurrence of non-small cell lung cancer in the liver.
    Ishige F; Takayama W; Chiba S; Hoshino I; Arimitsu H; Yanagibashi H; Iwatate Y
    Int J Clin Oncol; 2018 Aug; 23(4):647-651. PubMed ID: 29511939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
    Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
    Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resection rate and outcome of pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland.
    Thorsteinsson H; Alexandersson A; Oskarsdottir GN; Skuladottir R; Isaksson HJ; Jonsson S; Gudbjartsson T
    J Thorac Oncol; 2012 Jul; 7(7):1164-9. PubMed ID: 22592213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters.
    Seder CW; Arndt AT; Jordano L; Basu S; Fhied CL; Sayidine S; Chmielewski GW; Gallo K; Liptay MJ; Borgia JA
    Ann Thorac Surg; 2017 Nov; 104(5):1637-1643. PubMed ID: 28964418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer.
    Hamaji M; Allen MS; Cassivi SD; Deschamps C; Nichols FC; Wigle DA; Shen KR
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):683-90; discussion 690-1. PubMed ID: 23414986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of surgically resected peripheral non-small cell lung cancer with a tumor diameter of 1.0 cm or less.
    Baba T; Uramoto H; Kuwata T; Oka S; Shigematsu Y; Nagata Y; Shimokawa H; Takenoyama M; Hanagiri T; Tanaka F
    Scand J Surg; 2011; 100(3):153-8. PubMed ID: 22108741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
    Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
    J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.